Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia

NCT06644573 is registered in ClinicalTrials.gov with Nyree Penn as lead sponsor.

NCT NCT06644573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06644573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia
Lead sponsor
Nyree Penn
Phase
Phase 1
Overall status
Not yet recruiting
Start date
November 1, 2025
Completion date
May 1, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease or associated disorder, anesthesia, anxiety, athletes, cancer pain, chronic insomnia, circadian dysregulation, circadian rhythm, depression, idiopathic hypersomnia, insomnia, insomnia comorbid to psychiatric disorder, insomnia disorders, insomnia due to anxiety and fear, insomnia due to other mental disorder, insomnia related to another mental condition, insomnia related to specified disorder, menopause related conditions, mental health, military activity, military combat stress reaction, pain, parkinsons, post trauma nightmares, post-traumatic, post-traumatic stress disorder complex, ptsd, ptsd - post traumatic stress disorder, rem behavior disorder, rem sleep behavior disorder, rem sleep measurement, shift work sleep disorder, sleep, sleep deprivation, sleep disorders, circadian rhythm, sleep quality, veterans